Ovid Therapeutics

$5.99
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-2.12%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell OVID and other stocks, options, and ETFs commission-free!

About OVID

Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY. The listed name for OVID is Ovid Therapeutics Inc. Common Stock.

CEO
Jeremy Max Levin
Employees
59
Headquarters
New York, New York
Founded
2014
Market Cap
379.98M
Price-Earnings Ratio
Dividend Yield
Average Volume
631.26K
High Today
$6.18
Low Today
$5.90
Open Price
$6.14
Volume
413.72K
52 Week High
$9.40
52 Week Low
$1.80

Collections

OVID Earnings

-$0.46
-$0.31
-$0.15
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
-$0.36 per share
Actual
-$0.28 per share

You May Also Like